Opinion
Video
Author(s):
Ralph DeFronzo, MD, leads a discussion on the evolving perception of autonomous adrenal hypercortisolism, highlighting that its prevelance is significantly greater than previously understood.
CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes
Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access
Investigating the Link Between Type 2 Diabetes and Infection
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
The HCPFive: Top News for Healthcare Providers from the Week of 1/26
FDA News Month in Review: January 2025